Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus

Launched by ASSIUT UNIVERSITY · Nov 21, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how certain fats in the blood, called lipids, are affected in young people who have recently been diagnosed with juvenile systemic lupus erythematosus (jSLE). The researchers want to understand how the activity of this disease influences lipid levels in these patients. By looking at these patterns, they hope to learn more about the relationship between jSLE and lipid profiles, which can help in managing the condition better.

To participate in the trial, you need to be between 5 and 18 years old and have been diagnosed with jSLE based on specific medical guidelines. If you are currently taking medications to lower lipid levels or have another autoimmune disease, you won’t be able to join. Participants can expect to have their lipid levels checked and monitored throughout the study, helping researchers gather important data that could lead to better treatment options for young people with SLE.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients who are diagnosed according to 2019 European League against Rheumatism (EULAR) /American College of Rheumatology (ACR) SLE classification criteria .
• • 2. Patients diagnosed with jSLE between 5 and 18 years of age
• Exclusion Criteria:
• • 1. Patients on lipid lowering drugs for any other reason. 2. Patients with other autoimmune disease.